However, the expression of FABP1 was not significantly correlated with clinical-pathological features such as age, gender, tumor size, histopathological type, lymph node positive, TNM stage, and HER2 positive (Figure 6(d) and Table 1). Here, ERBB2 is linked to neoplasm.